Skip to main content
Signal8

Satellos Bioscience Inc. (MSLE)

Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247 an oral, small-molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Satellos Bioscience Inc. Common Stock logo

Satellos Bioscience Inc. Common Stock

NASDAQ:MSLEHealthcare
-1.69%$6.70
Mkt Cap$142.15M
Float18.81M
O/S21.22M
Vol
$ Vol
RVOL
Inst Own36.2%
SI0.5%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$24.87M
Total Assets$31.89M
Free Cash Flow-$23.6M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$27.78M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
2-year cumulative
1:144

Nasdaq bars a compliance period at 1:250

  1. 1:12Reverse split
    Jan 30, 202612 shares → 1
  2. 1:12Reverse split
    Jan 30, 202612 shares → 1
Balance Sheet Details
Assets$31.89M
Liabilities$4.11M
Accounts Receivable$370K
Accounts Payable$1.77M
Inventory$0
PP&E (Net)$5K
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007
CurrencyUSDCADCADCADCADCADCADCADCADCADCADCADCADCADCADCADCADCADCAD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$101K$0$0$0
YoY Growth-------------------
Cost of Revenue$5K$20K$5K$3.73M$167K$893K$3K$2K$24K$28K$22K$47K$83K$88K$109K$0$472K$0$0
Gross Profit-$5K-$20K-$5K-$3.73M-$167K-$893K-$3K-$2K-$24K-$28K-$22K-$47K-$83K-$88K-$109K$0-$472K$0$0
Gross Margin-------------------
Research and Development$18.43M$13.66M$6.65M$3.73M$2M$893K$942K$1.42M$799K$569K$626K$594K$3.79M$2.21M$1.03M$1.67M$1.13M$1.24M$3.7M
Selling, General, and Administrative$7.44M$5.16M$4.57M$4.69M$2.62M$988K$1.32M$777K$673K$644K$1.56M$1.52M$1.96M$1.38M$1.33M$1.44M$190K$1.03M$541K
Other$595K$555K$442K-$3.73M$0$0$0$0$0$0$0$0$0$0$0$0$483K$0$797K
Total Operating Expenses$26.46M$19.38M$11.66M$4.69M$4.63M$1.88M$2.26M$2.19M$1.47M$1.21M$2.18M$2.11M$5.74M$3.58M$2.36M$3.11M$1.81M$2.27M$5.04M
Operating Income (EBIT)-$26.46M-$19.38M-$11.66M-$8.43M-$6.65M-$2.77M-$2.27M-$2.19M-$1.49M-$1.24M-$2.21M-$2.16M-$5.83M-$3.67M-$2.47M-$3.12M-$2.28M-$2.37M-$5.15M
Operating Margin----------------3106.3%---
Interest Expense$0$0$133K$0$773K$499$0$0$0$0$0$0$0$0$0$0$0$0$0
Interest Income$1.36M$955K$1M$63K$6K$0$0$416$7K$17K$41K$34K$16K$8K$14K$27K$6K$27K$40K
Other Income (Expense)$1.76M-$203K-$321K-$2.89M-$8.86M$1.19M$3K$498K$239K-$261K$416K$240K$445K$19K$1.44M$2K-$31K-$27K-$15K
Income Before Tax (EBT)-$24.7M-$19.58M-$11.98M-$11.32M-$15.51M-$1.58M-$2.26M-$1.7M-$1.26M-$1.5M-$1.79M-$1.92M-$5.38M-$3.65M-$1.03M-$3.12M-$2.31M-$2.4M-$5.17M
Income Tax Expense$172K$0$0$5K$0$0-$272K$0$0$0$0$0$0$0$0$0$0$0$0
Net Income-$24.87M-$19.58M-$11.98M-$11.32M-$15.51M-$1.58M-$1.99M-$1.7M-$1.26M-$1.5M-$1.79M-$1.92M-$5.38M-$3.65M-$1.03M-$3.12M-$2.31M-$2.4M-$5.17M
Net Income Margin----------------3104.7%---
Supplementary Data
EPS-20.40-2.16-1.63-3.81-6.02-1.07-3.90-4.82-2.44-4.84-4.79-4.58-20.51-16.84-4.79-19.30-19.21-29.39-274.41
Diluted EPS-20.40-2.16-1.63-3.81-6.02-1.07-3.90-4.82-2.44-4.84-4.79-4.58-20.51-16.84-4.79-19.30-19.21-29.39-274.41
Weighted Average OS1.22M9.56M7.20M2.97M2.01M1.48M510,058351,907351,907351,907351,907351,907256,185206,248174,826170,232123,09383,65418,920
EBITDA-$26.45M-$19.56M-$11.84M-$8.11M-$4.73M-$1.61M-$2.26M-$2.19M-$1.47M-$1.21M-$2.18M-$2.11M-$5.74M-$3.58M-$2.36M-$3.01M-$2.16M-$2.27M-$5.04M
EBITDA Margin----------------2995.7%---
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007
CurrencyUSDCADCADCADCADCADCADCADCADCADCADCADCADCADCADCADCADCADCAD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Assets
Current Assets
Cash and Cash Equivalents$9.8M$40.18M$22.07M$1.9M$3.82M$709K$1.02M$10K$1.14M$2.38M$2.72M$3.53M$1.05M$601K$255K$636K$1.39M$543K$1.88M
Short-Term Investments$17.91M$8.5M$17.52M$0$0$10K$0$0$0$0$1.02M$1.93M$758K$662K$1.07M$1.42M$2.51M$0$42K
Cash and Short-Term Investments$27.71M$48.67M$39.59M$1.9M$3.82M$719K$1.02M$10K$1.14M$2.38M$3.74M$5.46M$1.81M$1.26M$1.32M$2.05M$3.9M$543K$1.92M
Accounts Receivable$370K$436K$0$257K$414K$410K$425K$129K$90K$37K$24K$37K$122K$25K$26K$46K$35K$38K$443K
Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Assets$0$0$587K$3K-$0$0$0$0$0$0$0$0$21K$0$0$0$0$0$0
Total Current Assets$31.88M$50.87M$40.32M$2.21M$4.27M$1.13M$1.5M$174K$1.39M$2.44M$3.79M$5.52M$1.96M$1.32M$1.4M$2.13M$3.96M$592K$2.38M
Long-Term Assets
Property, Plant & Equipment Net$5K$3K$19K$9K$6K$2K$6K$3K$2K$3K$6K$5K$6K$8K$8K$12K$17K$21K$15K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$3.92M$3.88M$5.6M$0$0$0$0$22K$43K$61K$141K$234K$318K$555K$659K$669K$868K
Long-Term Investments$0$0$41K$42K$0$0$0$0$0$3K$44K$1.18M$1.62M$1.44M$1.22M$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$23K$0$0$0$0$0
Total Long-Term Assets$5K$3K$3.98M$3.93M$5.6M$2K$6K$3K$2K$28K$92K$1.25M$1.77M$1.7M$1.54M$567K$676K$690K$883K
Other Assets$0$0$0-$988$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$31.89M$50.88M$44.3M$6.14M$9.87M$1.13M$1.51M$178K$1.4M$2.47M$3.89M$6.77M$3.73M$3.02M$2.94M$2.69M$4.63M$1.28M$3.27M
Liabilities
Current Liabilities
Accounts Payable$1.77M$2.07M$1.04M$1.45M$885K$0$0$0$0$0$0$1.44M$260K$119K$71K$86K$323K$387K$781K
Short-Term Debt$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Income Tax Payable$72K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Liabilities$0$0$0$0-$0$220K$830K$800K$293K$139K$115K$66K$2.24M$847K$184K$208K$0$0$0
Total Current Liabilities$4.11M$3.59M$3.62M$2.8M$1.65M$220K$830K$800K$293K$139K$115K$1.51M$2.5M$966K$255K$293K$323K$387K$781K
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$1.1M$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$0$0$0$0$0$1.1M$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$4.11M$3.59M$3.62M$2.8M$1.65M$1.32M$830K$800K$293K$139K$115K$1.51M$2.5M$966K$255K$293K$323K$387K$781K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$85.83M$73.67M$61.92M$29.91M$22.21M$4.36M$30.58M$27.96M$28.46M$28.25M$27.98M$26.81M$22.63M$20.02M$17.55M$16.89M$15.75M$9.33M$9.52M
Retained Earnings-$81.97M-$52.68M-$47.5M-$31.3M-$15.91M-$4.8M-$37.99M-$34.93M-$33.83M-$32.34M-$30.54M-$27.55M-$25.46M-$21.19M-$17.46M-$16.56M-$13.37M-$9.67M-$8.28M
Comprehensive Income & Other-$1.72M-$151K$17.76M-$7K-$1K$1.44M$1.47M$2.08M$2.9M$2.87M$2.85M$2.66M$1.06M$812K$373K$81K$335K$0$785K
Other Stockholders' Equity$23.93M$26.29M$26.26M$4.73M$1.93M$247K$8.09M$6.35M$6.47M$6.42M$6.33M$6M$4.06M$3.22M$2.6M$2.07M$1.94M$1.23M$1.24M
Total Equity$27.78M$47.28M$40.67M$3.34M$8.22M-$184K$679K-$623K$1.1M$2.33M$3.77M$5.26M$1.23M$2.05M$2.69M$2.4M$4.31M$895K$2.49M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$31.89M$50.88M$44.3M$6.14M$9.87M$1.13M$1.51M$178K$1.4M$2.47M$3.89M$6.77M$3.73M$3.02M$2.94M$2.69M$4.63M$1.28M$3.27M
Supplementary Data
Total Debt$0$0$0$0$0$1.1M$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Debt-$9.8M-$40.18M-$22.07M-$1.9M-$3.82M$387K-$1.02M-$10K-$1.14M-$2.38M-$2.72M-$3.53M-$1.05M-$601K-$255K-$636K-$1.39M-$543K-$1.88M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007
CurrencyUSDCADCADCADCADCADCADCADCADCADCADCADCADCADCADCADCADCAD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Operating Activities
Net Income-$24.87M-$19.58M-$15.89M-$8.34M-$12.16M-$1.58M-$1.99M-$1.7M-$1.5M-$1.79M-$1.92M-$5.38M-$3.65M-$1.03M-$3.12M-$2.31M-$2.4M-$5.17M
Depreciation & Amortization$4K$14K$5K$320K$162K$422$3K$2K$28K$22K$47K$83K$88K$109K$111K$117K$101K$114K
Deferred Income Tax$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$3.23M$1.47M$1.64M$1.06M$762K$0$0$0$0$0$0$0$0$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable$65K-$30K-$243K$197K-$53K$256K-$292K-$41K-$13K$15K$86K-$98K$1K$20K-$11K$8K$351K-$426K
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$0$0$0$0$0-$446K$0$0$0$0-$1.06M$1.48M$699K-$36K-$31K-$120K-$298K$46K
  Other Working Capital-$1.54M-$684K$522K$533K-$328K$7K-$19K$635K$22K-$1.26M$8K$16K-$7K-$25K$1K-$9K$3K$20K
Total Working Capital Change-$1.48M-$714K$278K$730K-$381K-$183K-$311K$594K$9K-$1.25M-$969K$1.4M$693K-$42K-$41K-$121K$56K-$360K
Other Non-Cash Items-$484K$1.4M-$446K$568K$7.67M$101K$0$988$122K-$74K$135K$326K$103K-$969K$367K$190K$157K$1.51M
Net Cash from Operating-$23.6M-$17.4M-$14.42M-$5.66M-$3.95M-$1.66M-$2.3M-$1.1M-$1.34M-$3.09M-$2.71M-$3.57M-$2.77M-$1.93M-$2.68M-$2.12M-$2.08M-$3.9M
Investing Activities
Capital Expenditures-$6K-$4K-$14K-$2K-$6K$0-$6K-$3K-$4K-$2K$0$0-$3K-$2K-$7K-$3K-$16K-$11K
Acquisitions$0$0$0$0$1.37M$0$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments-$23.37M-$26.01M-$13.21M$0$0$0$0$0$0$0-$1.16M-$131K$0$0$0-$2.51M$0-$945K
Sales of Investments$13.96M$30.43M$0$0$0$0$0$0$0$1.99M$313K$0$411K$337K$1.11M$0$37K$1.54M
Other Investing Activities$0$0-$4.32M$0$0$0$0$0$0$0$0$0$0$179K$0$0$0$0
Net Cash from Investing-$9.42M$4.42M-$17.54M-$2K$1.36M$0-$6K-$3K-$4K$1.99M-$850K-$131K$408K$514K$1.1M-$2.52M$21K$585K
Financing Activities
Debt Repaid--$284K--$146K-$1.09M------------
Common Stock Issuance$2.24M$29.82M$24.47M$2.04M$5.55M$893K$3.31M$0$0$0$5.99M$4.2M$2.7M$1.04M$826K$5.41M$954K$4.24M
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$7.44M$26.77M$703K$145K$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Cash from Financing$2.24M$37.27M$50.95M$2.75M$5.84M$1.98M$3.31M$0$0$0$5.99M$4.2M$2.7M$1.04M$826K$5.41M$954K$4.24M
Forex Effect$503K$518K$2.28M$1.75M-$1K-$585K$7K-$111K$1.07M-$603K-$54K-$60K$8K-$16K$73K$94K-$414K$958K
Net Change in Cash-$30.27M$24.8M$21.27M-$1.17M$3.26M-$266K$1.01M-$1.22M-$274K-$1.7M$2.38M$441K$350K-$392K-$684K$859K-$1.52M$1.88M
Supplementary Data
Operating Cash Flow-$23.6M-$17.4M-$14.42M-$4.26M-$3.95M-$1.66M-$2.3M-$1.1M-$1.34M-$3.09M-$2.71M-$3.57M-$2.77M-$1.93M-$2.68M-$2.12M-$2.08M-$3.9M
Capital Expenditure-$6K-$4K-$18K-$2K-$6K$0-$6K-$3K-$4K-$2K$0$3-$3K-$2K-$7K-$3K-$16K-$11K
Free Cash Flow-$23.6M-$17.41M-$14.44M-$4.26M-$3.95M-$1.66M-$2.3M-$1.1M-$1.35M-$3.09M-$2.71M-$3.57M-$2.77M-$1.93M-$2.69M-$2.13M-$2.1M-$3.91M
Cash at Beginning$40.07M$15.38M$1.92M$4.87M$563K$975K$10K$1.23M$2.65M$4.42M$1.15M$607K$250K$647K$1.32M$527K$2.07M$0
Cash at End$9.8M$40.18M$22.07M$1.92M$3.82M$709K$1.02M$10K$2.38M$2.72M$3.53M$1.05M$601K$255K$636K$1.39M$543K$1.88M